Bibliografia UJ CM

1/17
Tomas Jelinek, Renata Bezdekova, David Zihala, Tereza Sevcikova, Anjana Anilkumar Sithara, Lenka Pospisilova, Sabina Sevcikova, Petra Polackova, Martin Stork, Zdenka Knechtova, Ondrej Venglar, Veronika Kapustova, Tereza Popkova, Ludmila Muronova, Zuzana Chyra, Matous Hrdinka, Michal Simicek, Juan-Jose Garces, Noemi Puig, Maria-Teresa Cedena, Artur Jurczyszyn, Jorge J. Castillo, Miroslav Penka, Jakub Radocha, Maria Victoria Mateos, Jesus F. San-Miguel, Bruno Paiva, Ludek Pour, Lucie Rihova, Roman Hajek.
More than 2% of circulating tumor plasma cells defines plasma cell leukemia-like multiple myeloma
Journal of Clinical Oncology
2023 : Vol. 41, nr 7, s. 1383-1392, il., bibliogr., abstr.
Autor korespondencyjny: Roman Hajek
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0
Online First 2022-10-31
p-ISSN: 0732-183X
e-ISSN: 1527-7755
AZ
ORG
AIF
IF: 45.300
Adres url:
Streszczenie w PubMed:
2/17
Zuzana Chyra, Tereza Sevcikova, Petr Vojta, Janka Puterova, Lucie Brozova, Katerina Growkova, Jana Filipova, Martina Zatopkova, Sebastian Grosicki, Agnieszka Barchnicka, Wieslaw Wiktor Jedrzejczak, Anna Waszczuk-Gajda, Alexandra Jungova, Aneta Mikulasova, Marian Hajduch, Martin Mokrejs, Ludek Pour, Martin Stork, Lubica Harvanova, Martin Mistrik, Gabor Mikala, Pawel Robak, Anna Czyz, Jakub Debski, Lidia Usnarska-Zubkiewicz, Artur Jurczyszyn, Lukas Stejskal, Gareth Morgan, Fedor Kryukov, Eva Budinska, Michal Simicek, Tomas Jelinek, Matous Hrdinka, Roman Hajek.
Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis.
Haematologica
2021 : Vol. 106, nr 2, s. 601-604, il., bibliogr. 14 poz.
Autor korespondencyjny: Roman Hajek.
p-ISSN: 0390-6078
LR
AIF
IF: 11.049
Adres url:
Streszczenie w PubMed:
3/17
Philippe Moreau, Shaji K. Kumar, Jesús San Miguel, Faith Davies, Elena Zamagni, Nizar Bahlis, Heinz Ludwig, Joseph Mikhael, Evangelos Terpos, Fredrik Schjesvold, Thomas Martin, Kwee Yong, Brian G.M. Durie, Thierry Facon, Artur Jurczyszyn, Surbhi Sidana, Noopur Raje, Niels van de Donk, Sagar Lonial, Michele Cavo, Sigurdur Y. Kristinsson, Suzanne Lentzsch, Roman Hajek, Kenneth C. Anderson, Cristina Joao, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt, Rafael Fonseca, Annette Vangsted, Katja Weisel, Rachid Baz, Vania Hungria, Jesus G. Berdeja, Fernando Leal da Costa, Angelo Maiolino, Anders Waage, David H. Vesole, Enrique M. Ocio, Hang Quach, Christoph Driessen, Joan Bladé, Xavier Leleu, Eloisa Riva, Peter Leif Bergsage, Jian Ho, Wee Joo Chng, Ulf-Henrik Mellqvist, Dominik Dytfeld, Jean-Luc Harousseau, Hartmut Goldschmidt, Jacob Laubach, Nikhil C. Munshi, Francesca Gay, Meral Beksac, Luciano J. Costa, Martin Kaiser, Parameswaran Hari, Mario Boccadoro, Saad Z. Usmani, Sonja Zweegman, Sarah Holstein, Orhan Sezer, Simon Harrison, Hareth Nahi, Gordon Cook, Maria-victoria Mateos, S. Vincent Rajkumar, Meletios A. Dimopoulos, Paul G. Richardson.
Treatment of relapsed and refractory multiple myeloma : recommendations from the International Myeloma Working Group.
Lancet. Oncology
2021 : Vol. 22, nr 3, s. e105-e118, il., bibliogr. 66 poz.
Autor korespondencyjny: Philippe Moreau.
p-ISSN: 1470-2045
AZ
POG
AIF
IF: 54.433
Adres url:
Streszczenie w PubMed:
4/17
Sebastian Grosicki, Maryana Simonova, Ivan Spicka, Ludek Pour, Iryrna Kriachok, Maria Gavriatopoulou, Halyna Pylypenko, Holger W. Auner, Xavier Leleu, Vadim Doronin, Ganna Usenko, Nizar J. Bahlis, Roman Hajek, Reuben Benjamin, Tuphan K. Dolai, Dinesh K. Sinha, Christopher P. Venner, Mamta Garg, Mercedes Gironella, Artur Jurczyszyn, Pawel Robak, Monica Galli, Craig Wallington-Beddoe, Atanas Radinoff, Galina Salogub, Don A. Stevens, Supratik Basu, Anna M. Liberati, Hang Quach, Vesselina S. Goranova-Marinova, Jelena Bila, Eirini Katodritou, Hanna Oliynyk, Sybiryna Korenkova, Jeevan Kumar, Sundar Jagannath, Phillipe Moreau, Moshe Levy, Darrell White, Moshe E. Gatt, Thierry Facon, Maria V. Mateos, Michele Cavo, Donna Reece, Larry D. Anderson Jr, Jean-Richard Saint-Martin, Jacqueline Jeha, Anita A. Joshi, Yi Chai, Lingling Li, Vishnuvardhan Peddagali, Melina Arazy, Jatin Shah, Sharon Shacham, Michael G. Kauffman, Meletios A. Dimopoulos, Paul G. Richardson, Sosana Delimpasi.
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON) : a randomised, open-label, phase 3 trial.
Lancet
2020 : Vol. 396, nr 10262, s. 1563-1573, il., bibliogr. 33 poz., sum.
Autor korespondencyjny: Sebastian Grosicki.
p-ISSN: 0140-6736
AZ
ORG
AIF
IF: 79.323
Adres url:
Streszczenie w PubMed:
5/17
Anna Suska, David H. Vesole, Jorge J. Castillo, Shaji K. Kumar, Hari Parameswaran, Maria V. Mateos, Thierry Facon, Alessandro Gozzetti, Gabor Mikala, Marta Szostek, Joseph Mikhael, Roman Hajek, Evangelos Terpos, Artur Jurczyszyn.
Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers?
Clinical Hematology International
2020 : Vol. 2, nr 4, s. 133-142, il., bibliogr., abstr.
Autor korespondencyjny: Artur Jurczyszyn.
Open Access Creative Commons Attribution License CC-BY-NC 4.0.
e-ISSN: 2590-0048
AZ
ORG
APZ
Adres url:
6/17
Thierry Facon, Jae Hoon Lee, Philippe Moreau, Ruben Niesvizky, Meletios Dimopoulos, Roman Hajek, Ludek Pour, Artur Jurczyszyn, Lugui Qiu, Zandra Klippel, Anita Zahlten-Kumeli, Muhtarjan Osman, Bruno Paiva, Jesus San-Miguel.
Carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible patients with newly diagnosed multiple myeloma.
Blood
2019 : Vol. 133, nr 18, s. 1953-1963, il., bibliogr. 32 poz., abstr.
Auto korespondencyjny: Thierry Facon.
p-ISSN: 0006-4971
AZ
ORG
AIF
IF: 17.794
Adres url:
Streszczenie w PubMed:
7/17
Artur Jurczyszyn, Julio Davila, K. Martin Kortum, David S. Jayabalan, Ravi Vij, Mark Fiala, Vibor Milunovic, C.S. Chim, Katarzyna Wiśniewska-Piąty, Anna Waszczuk-Gajda, Edvan Crusoe, Roman Hajek, Paweł Robak, Małgorzata Raźny, Daria Zawirska, Max Bittrich, Hareth Nahi, Jieqi Liu, Jorge J. Castillo, David H. Vesole.
Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases.
Leukemia & Lymphoma
2019 : Vol. 60, nr 2, s. 471-476
Autor korespondencyjny: Artur Jurczyszyn.
p-ISSN: 1042-8194
AZ
ORG
AIF
IF: 2.969
Adres url:
Streszczenie w PubMed:
DOI:
8/17
Artur Jurczyszyn, Jorge J. Castillo, Irit Avivi, Jacek Czepiel, Julio Davila, Ravi Vij, Mark A. Fiala, Alessandro Gozzetti, Norbert Grząśko, Vibor Milunovic, Iwona Hus, Krzysztof Mądry, Anna Waszczuk-Gajda, Lidia Usnarska-Zubkiewicz, Jakub Dębski, Erden Atilla, Meral Beksac, Giuseppe Mele, Waldemar Sawicki, David Jayabalan, Grzegorz Charliński, Agoston Gyula Szabo, Roman Hajek, Michel Delforge, Agnieszka Kopacz, Dorotea Fantl, Anders Waage, Edvan Crusoe, Vania Hungria, Paul Richardson, Jacob Laubach, Thomas Guerrero-Garcia, Jieqi Liu, David H. Vesole.
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients.
Leukemia & Lymphoma
2019 : Vol. 60, nr 1, s. 118-123, bibliogr., abstr.
Autor korespondencyjny: Artur Jurczyszyn.
p-ISSN: 1042-8194
AZ
ORG
AIF
IF: 2.969
Adres url:
Streszczenie w PubMed:
DOI:
9/17
Artur Jurczyszyn, Jakub Radocha, Julio Davila, Mark A. Fiala, Alessandro Gozzetti, Norbert Grząśko, Paweł Robak, Iwona Hus, Anna Waszczuk-Gajda, Renata Guzicka-Kazimierczak, Erden Atilla, Giuseppe Mele, Waldemar Sawicki, David S. Jayabalan, Grzegorz Charliński, Agoston G. Szabo, Roman Hajek, Michel Delforge, Agnieszka Kopacz, Dorotea Fantl, Anders Waage, Irit Avivi, Marek Rodzaj, Xavier Leleu, Valentine Richez, Wanda Knopińska-Posłuszny, Anna Masternak, Andrew J. Yee, Agnieszka Barchnicka, Agnieszka Druzd-Sitek, Thomas Guerrero-Garcia, Jieqi Liu, David H. Vesole, Jorge J. Castillo.
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients
British Journal of Haematology
2018 : Vol. 180, nr 6, s. 831-839, il., bibliogr.
Autor korespondencyjny: Artur Jurczyszyn.
p-ISSN: 0007-1048
AZ
ORG
AIF
IF: 5.206
Adres url:
Streszczenie w PubMed:
10/17
Norbert Grzasko, Roman Hajek, Marek Hus, Sylwia Chocholska, Marta Morawska, Krzysztof Giannopoulos, Krzysztof Czarnocki, Agnieszka Druzd-Sitek, Barbara Pieńkowska-Grela, Jolanta Rygier, Lidia Usnarska-Zubkiewicz, Dominik Dytfeld, Tadeusz Kubicki, Artur Jurczyszyn, Maciej Korpysz, Anna Dmoszynska.
Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group.
Leukemia & Lymphoma
2017 : Vol. 58, nr 9, s. 2089-2100
Autor korespondencyjny: Norbert Grzasko.
p-ISSN: 1042-8194
AZ
ORG
AIF
IF: 2.644
Adres url:
Streszczenie w PubMed:
DOI:
11/17
Jorge J. Castillo, Artur Jurczyszyn, Lucie Brozova, Edvan Crusoe, Jacek Czepiel, Julio Davila, Angela Dispenzieri, Marion Eveillard, Mark A. Fiala, Irene M. Ghobrial, Alessandro Gozzetti, Joshua N. Gustine, Roman Hajek, Vania Hungria, Jiri Jarkovsky, David Jayabalan, Jacob P. Laubach, Barbara Lewicka, Vladimir Maisnar, Elisabet E. Manasanch, Philippe Moreau, Elizabeth A. Morgan, Hareth Nahi, Ruben Niesvizky, Claudia Paba-Prada, Tomas Pika, Ludek Pour, John L. Reagan, Paul G. Richardson, Jatin Shah, Ivan Spicka, Ravi Vij, Anna Waszczuk-Gajda, Morie A. Gertz.
IgM Myeloma: A Multicenter Retrospective Study of 134 Patients.
American Journal of Hematology
2017 : Vol. 92, nr 8, s. 746-751, il., bibliogr. 37 poz., abstr.
Autor korespondencyjny: Jorge J. Castillo.
Jorge J. Castillo ; Artur Jurczyszyn - Both authors share first authorship.
p-ISSN: 0361-8609
AZ
ORG
AIF
IF: 5.303
Adres url:
Streszczenie w PubMed:
12/17
Sebastian Grosicki, Agnieszka Barchnicka, Małgorzata Gajewska, Erden Atilla, Meral Beksac, Roman Hajek, Daniel Horinek, Anna Waszczuk-Gajda, Krzysztof Mądry, Barbara Lewicka, Renata Guzicka-Kazimierczak, Artur Jurczyszyn.
Results of treatment of multiple myeloma secondary to anticancer therapy - international, multicenter retrospective study.
Acta Haematologica Polonica
2017 : Vol. 48, suppl. 1, s. s72.
XXVII Zjazd Polskiego Towarzystwa Hematologów i Transfuzjologów, Warszawa, 21-23 września 2017 r.
p-ISSN: 0001-5814
SZP
AWZ
13/17
Meletios A. Dimopoulos, Philippe Moreau, Antonio Palumbo, Douglas Joshua, Ludek Pour, Roman Hajek, Thierry Facon, Heinz Ludwig, Albert Oriol, Hartmut Goldschmidt, Laura Rosinol, Jan Straub, Aleksandr Suvorov, Carla Araujo, Elena Rimashevskaya, Tomas Pika, Gianluca Gaidano, Katja Weisel, Vesselina Goranova-Marinova, Anthony Schwarer, Leonard Minuk, Tamas Masszi, Ievgenii Karamanesht, Massimo Offidani, Vania Hungria, Andrew Spencer, Robert Z. Orlowski, Heidi H. Gillenwater, Nehal Mohamed, Shibao Feng, Wee-Joo Chng, ENDEAVOR investigators.
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
Lancet. Oncology
2016 : Vol. 17, nr1, s. 27-38, il., bibliogr. 23 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 33.900
Adres url:
Streszczenie w PubMed:
14/17
Norbert Grzasko, Marek Hus, Andrzej Pluta, Artur Jurczyszyn, Adam Walter-Croneck, Marta Morawska, Sylwia Chocholska, Roman Hajek, Anna Dmoszynska.
Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients.
Hematol. Oncol.
2013 : Vol. 31, nr 1, s. 41-48, il., bibliogr. 33 poz., abstr.
p-ISSN: 0278-0232
AZ
ORG
AIF
IF: 2.355
Adres url:
Streszczenie w PubMed:
15/17
Jan Smetana, Kristina Berankova, Romana Zaoralova, Pavel Nemec, Henrieta Greslikova, Renata Kupska, Aneta Mikulasova, Jan Frohlich, Sabina Sevcikova, Lucie Zahradova, Marta Krejci, Viera Sandecka, Martina Almasi, Petra Kaisarova, Hana Melicharova, Zdenek Adam, Miroslav Penka, Jiri Jarkovsky, Arthur [Artur] Jurczyszyn, Roman Hajek, Petr Kuglik.
Gain(1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomib.
Clinical Lymphoma, Myeloma and Leukemia
2013 : Vol. 13, nr 2, s. 123-130, il., bibliogr. 47 poz., abstr.
p-ISSN: 2152-2650
e-ISSN: 2152-2669
AZ
ORG
AIF
IF: 1.929
16/17
Multiple Myeloma - A Quick Reflection on the Fast Progress.
ed. by Roman Hajek.
Rijeka : InTech, 2013
334 s.
Publikacja nie należy do dorobku UJ CM.
p-ISBN: 978-953-51-1083-5
000
17/17
Antonio Palumbo, Roman Hajek, Michel Delforge, Martin Kropff, Maria Teresa Petrucci, John Catalano, Heinz Gisslinger, Wiesław Wiktor Jędrzejczak, Mamia Zodelava, Katja Weisel, Nicola Cascavilla, Genadi Iosava, Michele Cavo, Janusz Kloczko, Joan Blade, Meral Beksac, Ivan Spicka, Torben Plesner, Joergen Radke, Christian Langer, Dina Ben Yehuda, Alessandro Corso, Lindsay Herbein, Zhinuan Yu, Jay Mei, Christian Jacques, Meletios A. Dimopoulos, MM-015 Investigators.
Continuous lenalidomide treatment for newly diagnosed multiple myeloma.
New England Journal of Medicine
2012 : Vol. 366, nr 19, s. 1759-1769, il., bibliogr. 25 poz., abstr.
p-ISSN: 0028-4793
AZ
ORG
AIF
IF: 51.658
Adres url:
Streszczenie w PubMed:
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ